Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing: Serum IGF-1 and traumatic brain injury
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The diagnosis of growth hormone deficiency (GHD) in adults is established through growth hormone (GH) stimulation testing, which is often complex, expensive, time-consuming and may be associated with adverse side effects. The decision to perform GH provocative testing is influenced by clinical findings, medical history and biochemical evidence. We report in this study our experience using the glucagon stimulation test (GST) in assessing GHD in adult patients with traumatic brain injury (TBI) as it relates to baseline serum insulin-like growth factor-1 (IGF-1) concentrations. DESIGN: A receiver operating characteristic (ROC) curve analysis was performed to determine the optimal IGF-1 cut-off for diagnosis of GHD at different potential diagnostic GST cut-off values (<3, <5, & <10 μg/l). PATIENTS: One hundred and thirty-eight patients (98 men and 40 women) with a documented history of moderate to severe TBI were assessed for GHD using serum IGF-1 concentrations and the GST. MEASUREMENTS: IGF-1 values were compared with peak GH values obtained following the GST. RESULTS: An IGF-1 cut-off value of 175 μg/l minimized the misclassification of GHD patients and GH-sufficient patients and provided a sensitivity of 83% and specificity of 40%, as well as a negative predictive power of 90% considering a criterion for peak GH response of <3 μg/l. CONCLUSIONS: Our current findings are consistent with previous work assessing peak GH response using the insulin tolerance test (ITT) in a non-TBI sample, suggesting that diagnostic accuracy may be optimized if the GST is used when obtained serum IGF-1 concentrations are below 175 μg/l. While the decision to perform provocative testing to assess GHD in adult patients should be based on the clinician's clinical impression, the findings from this retrospective study can provide useful clinical information and serve as a guide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Ho, K. K. Y., & _, _. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0631 · Cited by 615
Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency
Biller, B. M. K., Samuels, M. H., Zagar, A., Cook, D. M., Arafah, B. M., Bonert, V., Stavrou, S., Kleinberg, D. L., Chipman, J. J., & Hartman, M. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8509 · Cited by 423
Prevalence of Neuroendocrine Dysfunction in Patients Recovering from Traumatic Brain Injury
Lieberman, S. A. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.6.2752 · Cited by 261
Effect of growth hormone replacement therapy on cognition after traumatic brain injury
High, W. M., Briones-Galang, M., Clark, J. A., Gilkison, C., Mossberg, K. A., Zgaljardic, D. J., Masel, B. E., & Urban, R. J. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1253 · Cited by 176
Self-citationJones, S. L., Trainer, P. J., Perry, L., Wass, J. A. H., Besser, G. M., & Grossman, A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03793.x · Cited by 159
Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults
Gómez, J. M., Espadero, R. M., Escobar‐Jiménez, F., Hawkins, F., Picó, A., Herrera‐Pombo, J. L., Vilardell, E., Durán, A., Mesa, J., Faure, E., et al. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01472.x · Cited by 130
GH deficiency as the most common pituitary defect after TBI: clinical implications
Popovic, V. (2005) · Pituitary · doi:10.1007/s11102-006-6047-z · Cited by 68
Bhagia, V., Gilkison, C., Fitts, R. H., Zgaljardic, D. J., High, W. M., Masel, B. E., Urban, R. J., & Mossberg, K. A. (2010) · Brain Injury · doi:10.3109/02699051003601705 · Cited by 35
Self-citation
Cited by
Wilkinson, C. W., Pagulayan, K. F., Petrie, E. C., Mayer, C. L., Colasurdo, E. A., Shofer, J. B., Hart, K. L., Hoff, D., Tarabochia, M. A., & Peskind, E. R. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00011 · Cited by 162
“Markedly low IGF-I levels are strong indicators of adult GHD (Juul et al., 1997; Hartman et al., 2002; Hadjadj et al., 2007; Ho, 2007; Prodam et al., 2008; Tanriverdi et al., 2011; Zgaljardic et al., 2011).”
BackgroundLauzier, F., Turgeon, A. F., Boutin, A., Shemilt, M., Côté, I., Lachance, O., Archambault, P. M., Lamontagne, F., Moore, L., Bernard, F., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000046 · Cited by 68
Undurti, A., Colasurdo, E. A., Sikkema, C. L., Schultz, J. S., Peskind, E. R., Pagulayan, K. F., & Wilkinson, C. W. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00072 · Cited by 44
Detection of Growth Hormone Deficiency in Adults with Chronic Traumatic Brain Injury
Kreber, L. A., Griesbach, G. S., & Ashley, M. J. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4127 · Cited by 44
Aljboor, G. S., Tulemat, A., Al-Saedi, A. R., Radoi, M. P., Toader, C., & Papacocea, T. M. (2024) · Neurosurgical Review · doi:10.1007/s10143-024-03088-3 · Cited by 30
Metadata
- Authors
- Zgaljardic, D. J., Guttikonda, S., Grady, J. J., Gilkison, C. R., Mossberg, K. A., High Jr, W. M., Masel, B. E., & Urban, R. J.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2011-02-08
- Volume
- 74
- Issue
- 3
- Pages
- 365-369
- ISSN
- 0300-0664 (ISSN-L)
- OpenAlex
- W2119391156
- Cited by
- 22
- References
- 9
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing: Serum IGF-1 and traumatic brain injury. https://app.cochat.ai/papers/10.1111/j.1365-2265.2010.03935.x
- The paper
- Zgaljardic, D. J., Guttikonda, S., Grady, J. J., Gilkison, C. R., Mossberg, K. A., High Jr, W. M., Masel, B. E., & Urban, R. J. (2011). Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing: Serum IGF-1 and traumatic brain injury. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2010.03935.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.